Lumito’s labelling reagent kit (Scizys Erbium kit) has been successfully integrated with a fully automated laboratory staining procedure, a key step towards broader adoption in pharmaceutical and clinical research markets. With a verified protocol for the Leica BOND RX Fully Automated Research Stainer now in place, Concept Life Sciences are initiating testing on customer samples. The initial tests confirm that Lumitos technology delivers high sensitivity and exceptional, clear image quality, without disturbing autofluorescence, reinforcing Scizys’ potential for advanced tissue analysis.

“Having an independent partner verify the integration of our Erbium-based reagent kit with automated staining technology is a strong validation. Automated labelling protocols not only reduce manual effort and increase the throughput but also enhance consistency and reproducibility in the tissue analysis process. This makes our solution scalable and attractive for broader use by CROs and partners, accelerating adoption across the market”, says Sanna Wallenborg, CEO at Lumito.

“Lumito’s Scizys Erbium staining technology has successfully integrated into our automated staining workflows, delivering clear, high-sensitivity tissue images without autofluorescence. This enables faster and more sensitive analysis — bringing real value to our customers in pharmaceutical and clinical research”, says Chris Mills, Senior Scientist at Concept Life Sciences.

The evaluation concludes the first stage of the collaboration announced in a press release earlier this year on March 27, which focuses on optimising Scizys for use in Concept Life Sciences’ cutting-edge research service.